X0508 4/A 2024-03-15 2024-03-18 0001880438 AN2 Therapeutics, Inc. ANTX 0001914510 Day Lucy C/O AN2 THERAPEUTICS, INC. 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 true Chief Financial Officer false Common Stock 2024-03-15 4 A 0 27500 0 A 30627 D Previously reported on a Form 4 filed on March 18, 2024. As amended, the vesting schedule for the restricted stock units is as follows: 1/4th of the shares vests annually over four years from January 1, 2024, subject to the Reporting Person's continuous service as of such date. /s/ Lucy Day 2024-03-29